Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 267

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 267
---
 voted. When completing the internet process or the proxy card, you may specify whether your shares should be voted “FOR” or “AGAINST” or “ABSTAIN” from voting on all, some or none of the Proposals at the NLS Meeting. Attending the NLS Meeting The NLS Meeting will be held in person 4:00 pm, local time, on August 25, 2025, at the premises of Baker McKenzie Switzerland AG, Holbeinstrasse30, 8034 Zurich, Switzerland. In order to vote or submit a question during the NLS Meeting, you will also need the voter control number included on your proxy card. If you do not have the control number, you will not be able to vote or submit your questions during the NLS Meeting. 106 Revoking Your Proxy If a shareholder grants a proxy, it may still vote its shares itself if it revokes its proxy before the NLS Meeting by a signed notice of revocation. A shareholder may also change or revoke its vote by entering a new vote by internet or by submitting a later -datedproxy. With the representation by the independent proxy or a third party, a shareholder has no additional right of physical attendance at the NLS Meeting. Solicitation of Proxies NLS will bear the cost of soliciting proxies. In addition to these proxy materials, NLS’s directors and employees may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. NLS may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners. Other Matters As of the date of this proxy statement/prospectus, the NLS Board does not know of any business to be presented at the NLS Meeting other than as set forth in the notice accompanying this proxy statement/prospectus. If any other matters should properly come before the NLS Meeting, it is intended that the shares represented by proxies will be voted with respect to such matters in accordance with the judgment of the persons voting the proxies. Who Can Answer Your Questions About Voting Your Shares If you are a shareholder and have any questions about how to vote or direct a vote in respect of your NLS Common Shares or NLS Preferred Shares, you may contact NLS by mail (NLS Pharmaceutics Ltd., Alexander Zwyer, The Circle6, 8058 Zurich, Switzerland) or e -mail(acz@nls -pharma.com).